POST Online Media Lite Edition


Bone Biologics adds Mark Spilker to the board

Staff writer |
Thousand Oaks, Ca., USA - March 11, 2010, Thousand Oaks, Ca., USA - Bone Biologics announced that Mark Spilker to the board of directors.

Over his career, Dr. Spilker has been responsible for leading development and program management teams in the areas of tissue-engineered biologics, electro-mechanical devices, and electronics. He has launched many new products and served as a company resource for best practices in product development and design controls.


What to read next

Xenetic Biosciences chairman Mark Leuchtenberger resigns
Synthetic Biologics director Steve H. Kanzer resigns
Heat Biologics adds John Prendergast to board